Atulya Medilink Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 23-10-2024
- Paid Up Capital ₹ 1.00 M
as on 23-10-2024
- Company Age 7 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.46 M
as on 23-10-2024
- Revenue -5.58%
(FY 2023)
- Profit 214.03%
(FY 2023)
- Ebitda 18.17%
(FY 2023)
- Net Worth 58.88%
(FY 2023)
- Total Assets 1.02%
(FY 2023)
About Atulya Medilink
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹3.46 M.
Manish Kumar and Ram Naresh serve as directors at the Company.
- CIN/LLPIN
U24304HR2017PTC068909
- Company No.
068909
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 May 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Sonipat, Haryana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Atulya Medilink Private Limited offer?
Atulya Medilink Private Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Diabetic Herbal Medicine, Digestive System Drugs & Medicines, Antacid Drugs, Ayurvedic Herbal Syrups & Tonics, Ayurvedic Pain Relief Oil, Hand Sanitizers & Personal Hygiene, Hand Sanitizer & Disinfectant, Nutraceuticals & Dietary Supplements, Weight Loss Supplement.
Who are the key members and board of directors at Atulya Medilink?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manish Kumar  | Director | 04-May-2017 | Current |
| Ram Naresh | Director | 04-May-2017 | Current |
Financial Performance of Atulya Medilink.
Atulya Medilink Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 5.58% decrease. The company also saw a substantial improvement in profitability, with a 214.03% increase in profit. The company's net worth Soared by an impressive increase of 58.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Atulya Medilink?
In 2023, Atulya Medilink had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 06 Jul 2020 | ₹3.46 M | Open |
How Many Employees Work at Atulya Medilink?
Atulya Medilink has a workforce of 33 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Atulya Medilink, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Atulya Medilink's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
